Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire?

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 11, 2013, Pages 1363-1370

  Li, Jin ^a   Xu, Jiahong ^b   Cheng, Yan ^b   Wang, Fei ^b   Song, Yang ^b   Xiao, Junjie ^a  

^a SHANGHAI UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute coronary syndromes; Biomarker; MicroRNA; Plasma; Serum

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ACUTE CORONARY SYNDROME; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; HEART MUSCLE; HUMAN; METABOLISM; PHYSIOLOGY; PLASMA; PROGNOSIS; REVIEW; SERUM; SKELETAL MUSCLE;

ACUTE CORONARY SYNDROMES; BIOMARKER; MICRORNA; PLASMA; SERUM;

ACUTE CORONARY SYNDROME; ANIMALS; BIOLOGICAL MARKERS; HUMANS; MICRORNAS; MUSCLE, SKELETAL; MYOCARDIUM; ORGAN SPECIFICITY; PROGNOSIS;

EID: 84891158473     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12148     Document Type: Review

References (54)

1. West NE. The Year in Cardiology 2012: acute coronary syndromes. Eur Heart J. 2013; 34: 422-6.
2. Falk E, Nakano M, Bentzon JF, et al. Update on acute coronary syndromes: the pathologists' view. Eur Heart J. 2013; 34: 719-28.
3. Oerlemans MI, Mosterd A, Dekker MS, et al. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol Med. 2012; 4: 1176-85.
4. Engelhardt S, Small RNA. biomarkers come of age. J Am Coll Cardiol. 2012; 60: 300-3.
5. Bauersachs J, Thum T. Biogenesis and regulation of cardiovascular microRNAs. Circ Res. 2011; 109: 334-47.
6. Giordano S, Columbano A. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology. 2013; 57: 840-7.
7. Kim GH. MicroRNA regulation of cardiac conduction and arrhythmias. Transl Res. 2013; 161: 381-92.
8. Mayr M, Zampetaki A, Willeit P, et al. MicroRNAs within the continuum of postgenomics biomarker discovery. Arterioscler Thromb Vasc Biol. 2013; 33: 206-14.
9. Frankel LB, Lund AH. MicroRNA regulation of autophagy. Carcinogenesis. 2012; 33: 2018-25.
10. Ajit S. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors. 2012; 12: 3359-69.
11. Cortez MA, Bueso-Ramos C, Ferdin J, et al. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011; 8: 467-77.
12. Chen WJ, Yin K, Zhao GJ, et al. The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis. 2012; 222: 314-23.
13. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol. 2011; 80: 193-208.
14. Russo F, Di Bella S, Nigita G, et al. miRandola: extracellular circulating microRNAs database. PLoS ONE. 2012; 7: e47786.
15. Fan KL, Zhang HF, Shen J, et al. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Indian Heart J. 2013; 65: 12-6.
16. Yendamuri S, Kratzke R. MicroRNA biomarkers in lung cancer: MiRacle or quagMiRe? Transl Res. 2011; 157: 209-15.
17. Xu J, Zhao J, Evan G, et al. Circulating microRNAs: novel biomarkers for cardiovascular diseases. J Mol Med. 2012; 90: 865-75.
18. Pleister A, Selemon H, Elton SM, et al. Circulating miRNAs: novel biomarkers of acute coronary syndrome? In Biomark Med. 2013; 7: 287-305.
19. Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010; 31: 659-66.
20. Dimmeler S, Zeiher AM. Circulating microRNAs: novel biomarkers for cardiovascular diseases? Eur Heart J. 2010; 31: 2705-7.
21. D'Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010; 31: 2765-73.
22. Corsten MF, Dennert R, Jochems S, et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet. 2010; 3: 499-506.
23. Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci. 2010; 119: 87-95.
24. Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun. 2010; 391: 73-7.
25. Adachi T, Nakanishi M, Otsuka Y, et al. Plasma MicroRNA 499 as a biomarker of acute myocardial infarction. Clin Chem. 2010; 56: 1183-5.
26. Li C, Pei F, Zhu X, et al. Circulating microRNAs as novel and sensitive biomarkers of acute myocardial infarction. Clin Biochem. 2012; 45: 727-32.
27. Fichtlscherer S, Zeiher AM, Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol. 2011; 31: 2383-90.
28. Zampetaki A, Willeit P, Drozdov I, et al. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res. 2012; 93: 555-62.
29. Olivieri F, Antonicelli R, Lorenzi M, et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol. 2013; 167: 531-6.
30. Lippi G, Mattiuzzi C, Cervellin G. Circulating microRNAs (miRs) for diagnosing acute myocardial infarction: meta-analysis of available studies. Int J Cardiol. 2013; 167: 277-8.
31. Ji X, Takahashi R, Hiura Y, et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem. 2009; 55: 1944-9.
32. Cheng Y, Wang X, Yang J, et al. A translational study of urine miRNAs in acute myocardial infarction. J Mol Cell Cardiol. 2012; 53: 668-76.
33. Lu Y, Zhang Y, Wang N, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation. 2010; 122: 2378-87.
34. Wang R, Li N, Zhang Y, et al. Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Intern Med. 2011; 50: 1789-95.
35. Long G, Wang F, Duan Q, et al. Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS ONE. 2012; 7: e50926.
36. Long G, Wang F, Duan Q, et al. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci. 2012; 8: 811-8.
37. Lu HQ, Liang C, He ZQ, et al. Circulating miR-214 is associated with the severity of coronary artery disease. J Geriatric Cardiol. 2013; 10: 34-8.
38. Meder B, Keller A, Vogel B, et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol. 2011; 106: 13-23.
39. Zampetaki A, Willeit P, Tilling L, et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012; 60: 290-9.
40. Matsumoto S, Sakata Y, Nakatani D, et al. A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction. Biochem Biophys Res Commun. 2012; 427: 280-4.
41. Matsumoto S, Sakata Y, Nakatani D, et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res. 2013; 113: 322-6.
42. Widera C, Gupta SK, Lorenzen JM, et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol. 2011; 51: 872-5.
43. Bauters C, Kumarswamy R, Holzmann A, et al. Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction. Int J Cardiol. 2013. Doi:10.1016/j.ijcard.2012.12.074.
44. Eitel I, Adams V, Dieterich P, et al. Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction. Am Heart J. 2012; 164: 706-14.
45. Devaux Y, Vausort M, McCann GP, et al. MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction. Circ Cardiovasc Genet. 2013; 6: 290-8.
46. Gidlöf O, Smith JG, Miyazu K, et al. Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. BMC Cardiovasc Discord. 2013; 13: 12.
47. Willeit P, Zampetaki A, Dudek K, et al. Circulating MicroRNAs as novel biomarkers for platelet activation. Circ Res. 2013; 112: 595-600.
48. Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci. 2012; 37: 460-5.
49. Grasedieck S, Sorrentino A, Langer C, et al. Circulating microRNAs in hematological diseases: principles, challenges and perspectives. Blood. 2013; 121: 4977-84.
50. Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell. 2010; 39: 133-44.
51. van Empel VP, De Windt LJ, da Costa Martins PA. Circulating miRNAs: reflecting or affecting cardiovascular disease? Curr Hypertens Rep. 2012; 14: 498-509.
52. Goda T, Masuno K, Nishida J, et al. A label-free electrical detection of exosomal microRNAs using microelectrode array. Chem Commun (Camb). 2012; 48: 11942-4.
53. De Rosa S, Fichtlscherer S, Lehmann R, et al. Transcoronary concentration gradients of circulating microRNAs. Circulation. 2011; 124: 1936-44.
54. Stammet P, Goretti E, Vausort M, et al. Circulating microRNAs after cardiac arrest. Crit Care Med. 2012; 40: 3209-14.